China court speeds up drug-patent disputes, clarifies rules before generic launch
China has sped up court proceedings and clarified rules for resolving drug-patent disputes before generic medicines reach the market, giving drugmakers clearer guidance on protecting innovation and pursuing market entry.China has...To view the full article, register now.
Already a subscriber? Click here to view full article